Crohn Disease: Epidemiology, Diagnosis, and Management von Feuerstein, Joseph D., MD, Cheifetz, Adam S., MD

Volltext

Management of Active Crohn Disease von Cheifetz, Adam S

Volltext

Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel Diseases von Cheifetz, Adam S., MD, Gianotti, Robert, MD, Luber, Raphael, MD, Gibson, Peter R., MD

Volltext

Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies von Katsanos, Konstantinos H., Papamichael, Konstantinos, Feuerstein, Joseph D., Christodoulou, Dimitrios K., Cheifetz, Adam S.

Volltext

Infliximab trough concentrations during maintenance therapy are associated with endoscopic and histologic healing in ulcerative colitis von Papamichael, K., Rakowsky, S., Rivera, C., Cheifetz, A. S., Osterman, M. T.

Volltext

Psoriasis associated with anti‐tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature von Cullen, G., Kroshinsky, D., Cheifetz, A. S., Korzenik, J. R.

Volltext

Infliximab in inflammatory bowel disease von Papamichael, Konstantinos, Lin, Steve, Moore, Matthew, Papaioannou, Garyfallia, Sattler, Lindsey, Cheifetz, Adam S.

Volltext

Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy von Papamichael, Konstantinos, Cheifetz, Adam S

Volltext

Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease: A Cost-Effectiveness Analysis in a Simulated Cohort von Negoescu, Diana M, Enns, Eva A, Swanhorst, Brooke, Baumgartner, Bonnie, Campbell, James P, Osterman, Mark T, Papamichael, Konstantinos, Cheifetz, Adam S, Vaughn, Byron P

Volltext

Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic von Grossberg, Laurie B, Pellish, Randall S, Cheifetz, Adam S, Feuerstein, Joseph D

Volltext

Endogenous antisense RNA curbs CD39 expression in Crohn’s disease von Harshe, Rasika P., Xie, Anyan, Vuerich, Marta, Frank, Luiza Abrahão, Gromova, Barbora, Zhang, Haohai, Robles, Rene’ J., Mukherjee, Samiran, Csizmadia, Eva, Kokkotou, Efi, Cheifetz, Adam S., Moss, Alan C., Kota, Satya K., Robson, Simon C., Longhi, Maria Serena

Volltext

The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome von Lahiff, C., Safaie, P., Awais, A., Akbari, M., Gashin, L., Sheth, S., Lembo, A., Leffler, D., Moss, A. C., Cheifetz, A. S.

Volltext

Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care? von Papamichael, Konstantinos, Osterman, Mark T., Siegel, Corey A., Melmed, Gil Y., Dubinsky, Marla C., Colombel, Jean-Frederic, Hanauer, Stephen B., Cheifetz, Adam S.

Volltext

Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014 von Ballou, S., Hirsch, W., Singh, P., Rangan, V., Nee, J., Iturrino, J., Sommers, T., Zubiago, J., Sengupta, N., Bollom, A., Jones, M., Moss, A. C., Flier, S. N., Cheifetz, A. S., Lembo, A.

Volltext

Ulcerative colitis: epidemiology, diagnosis, and management von Feuerstein, Joseph D, Cheifetz, Adam S

Volltext

Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease? von Papamichael, Konstantinos, Cheifetz, Adam S

Volltext

A primer on common supplements and dietary measures used by patients with inflammatory bowel disease von Minhas, Hadi J, Papamichael, Konstantinos, Cheifetz, Adam S., Gianotti, Robert J.

Volltext

Etiology and Management of Lack or Loss of Response to Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease von Fine, Sean, Papamichael, Kostantinos, Cheifetz, Adam S

Volltext

Meta‐analysis: targeting the intestinal microbiota in prophylaxis for post‐operative Crohn’s disease von DOHERTY, G. A., BENNETT, G. C., CHEIFETZ, A. S., MOSS, A. C.

Volltext

Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis von Rostholder, E., Ahmed, A., Cheifetz, A. S., Moss, A. C

Volltext